iRhythm Technologies (IRTC) Projected to Post Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) will likely be releasing its earnings data after the market closes on Thursday, February 20th. Analysts expect iRhythm Technologies to post earnings of ($0.29) per share and revenue of $158.30 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

iRhythm Technologies Trading Up 0.3 %

NASDAQ:IRTC opened at $112.41 on Wednesday. The stock has a fifty day moving average price of $99.65 and a two-hundred day moving average price of $82.58. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of -23.13 and a beta of 1.29. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. iRhythm Technologies has a 1 year low of $55.92 and a 1 year high of $124.11.

Insider Activity at iRhythm Technologies

In related news, insider Patrick Michael Murphy sold 2,492 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $85.89, for a total transaction of $214,037.88. Following the sale, the insider now owns 35,327 shares of the company’s stock, valued at $3,034,236.03. This trade represents a 6.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.68% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on IRTC. Canaccord Genuity Group increased their price objective on iRhythm Technologies from $125.00 to $152.00 and gave the stock a “buy” rating in a research report on Monday, December 9th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $86.00 price objective on shares of iRhythm Technologies in a research report on Tuesday, December 3rd. Truist Financial increased their price objective on iRhythm Technologies from $85.00 to $111.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Oppenheimer increased their price objective on iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th. Finally, Needham & Company LLC upped their target price on iRhythm Technologies from $96.00 to $112.00 and gave the company a “buy” rating in a report on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $108.45.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.